These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 16503970
1. The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines. Alao JP, Gamble SC, Stavropoulou AV, Pomeranz KM, Lam EW, Coombes RC, Vigushin DM. Mol Cancer; 2006 Feb 17; 5():7. PubMed ID: 16503970 [Abstract] [Full Text] [Related]
2. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. Alao JP, Stavropoulou AV, Lam EW, Coombes RC, Vigushin DM. Mol Cancer; 2006 Feb 20; 5():8. PubMed ID: 16504004 [Abstract] [Full Text] [Related]
3. Role of cyclin D1 cytoplasmic sequestration in the survival of postmitotic neurons. Sumrejkanchanakij P, Tamamori-Adachi M, Matsunaga Y, Eto K, Ikeda MA. Oncogene; 2003 Nov 27; 22(54):8723-30. PubMed ID: 14647467 [Abstract] [Full Text] [Related]
4. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines. Alao JP, Lam EW, Ali S, Buluwela L, Bordogna W, Lockey P, Varshochi R, Stavropoulou AV, Coombes RC, Vigushin DM. Clin Cancer Res; 2004 Dec 01; 10(23):8094-104. PubMed ID: 15585645 [Abstract] [Full Text] [Related]
5. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Alt JR, Cleveland JL, Hannink M, Diehl JA. Genes Dev; 2000 Dec 15; 14(24):3102-14. PubMed ID: 11124803 [Abstract] [Full Text] [Related]
6. Cytoplasmic sequestration of cyclin D1 associated with cell cycle withdrawal of neuroblastoma cells. Sumrejkanchanakij P, Eto K, Ikeda MA. Biochem Biophys Res Commun; 2006 Feb 03; 340(1):302-8. PubMed ID: 16364255 [Abstract] [Full Text] [Related]
7. Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1. Zhou Q, Melkoumian ZK, Lucktong A, Moniwa M, Davie JR, Strobl JS. J Biol Chem; 2000 Nov 10; 275(45):35256-63. PubMed ID: 10938272 [Abstract] [Full Text] [Related]
8. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase. Kim YB, Lee KH, Sugita K, Yoshida M, Horinouchi S. Oncogene; 1999 Apr 15; 18(15):2461-70. PubMed ID: 10229197 [Abstract] [Full Text] [Related]
9. Isolation and characterization of cytoplasmic cyclin D1 mutants. Murakami H, Horihata M, Andojo S, Yoneda-Kato N, Kato JY. FEBS Lett; 2009 May 19; 583(10):1575-80. PubMed ID: 19409388 [Abstract] [Full Text] [Related]
10. Type 1 parathyroid hormone receptor (PTH1R) nuclear trafficking: regulation of PTH1R nuclear-cytoplasmic shuttling by importin-alpha/beta and chromosomal region maintenance 1/exportin 1. Pickard BW, Hodsman AB, Fraher LJ, Watson PH. Endocrinology; 2007 May 19; 148(5):2282-9. PubMed ID: 17317770 [Abstract] [Full Text] [Related]
11. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity. Dong J, Peng J, Zhang H, Mondesire WH, Jian W, Mills GB, Hung MC, Meric-Bernstam F. Cancer Res; 2005 Mar 01; 65(5):1961-72. PubMed ID: 15753396 [Abstract] [Full Text] [Related]
12. CDK4 protein is degraded by anaphase-promoting complex/cyclosome in mitosis and reaccumulates in early G1 phase to initiate a new cell cycle in HeLa cells. Chen H, Xu X, Wang G, Zhang B, Wang G, Xin G, Liu J, Jiang Q, Zhang H, Zhang C. J Biol Chem; 2017 Jun 16; 292(24):10131-10141. PubMed ID: 28446612 [Abstract] [Full Text] [Related]
13. An acidic environment changes cyclin D1 localization and alters colony forming ability in gliomas. Schnier JB, Nishi K, Harley WR, Gorin FA. J Neurooncol; 2008 Aug 16; 89(1):19-26. PubMed ID: 18404250 [Abstract] [Full Text] [Related]
14. Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells. Castoria G, Giovannelli P, Lombardi M, De Rosa C, Giraldi T, de Falco A, Barone MV, Abbondanza C, Migliaccio A, Auricchio F. Oncogene; 2012 Nov 15; 31(46):4868-77. PubMed ID: 22266855 [Abstract] [Full Text] [Related]
15. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. Okabe H, Lee SH, Phuchareon J, Albertson DG, McCormick F, Tetsu O. PLoS One; 2006 Dec 27; 1(1):e128. PubMed ID: 17205132 [Abstract] [Full Text] [Related]
16. Nuclear proteasomal degradation and cytoplasmic retention underlie early nuclear exclusion of transcription factor Max upon axon damage. Petrs-Silva H, Chiarini LB, Linden R. Exp Neurol; 2008 Sep 27; 213(1):202-9. PubMed ID: 18601921 [Abstract] [Full Text] [Related]
17. A regulatory role for CRM1 in the multi-directional trafficking of splicing snRNPs in the mammalian nucleus. Sleeman J. J Cell Sci; 2007 May 01; 120(Pt 9):1540-50. PubMed ID: 17405816 [Abstract] [Full Text] [Related]
18. Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm. Jackman M, Kubota Y, den Elzen N, Hagting A, Pines J. Mol Biol Cell; 2002 Mar 01; 13(3):1030-45. PubMed ID: 11907280 [Abstract] [Full Text] [Related]
19. Uncovering residues that regulate cyclin D1 proteasomal degradation. Feng Q, Sekula D, Müller R, Freemantle SJ, Dmitrovsky E. Oncogene; 2007 Aug 02; 26(35):5098-106. PubMed ID: 17310991 [Abstract] [Full Text] [Related]
20. Nuclear export of the human cytomegalovirus tegument protein pp65 requires cyclin-dependent kinase activity and the Crm1 exporter. Sanchez V, Mahr JA, Orazio NI, Spector DH. J Virol; 2007 Nov 02; 81(21):11730-6. PubMed ID: 17715235 [Abstract] [Full Text] [Related] Page: [Next] [New Search]